Syphilis and HIV: A dangerous combination

Lancet Infectious Diseases

Volumn 4, Issue 7, 2004, Pages 456-466

  Lynn, W A ^a,b   Lightman, S ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b EALING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENZATHINE PENICILLIN; CEFTRIAXONE; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN;

BACTERIAL TRANSMISSION; BONE DISEASE; BRAIN REGION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DRUG ABUSE; EYE DISEASE; FOLLOW UP; GENITAL ULCER; HEALTH PROGRAM; HEALTH SURVEY; HERXHEIMER REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INCIDENCE; INFECTION RISK; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NEUROSYPHILIS; PATIENT; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY; SEROPREVALENCE; SEXUAL BEHAVIOR; SKIN DISEASE; SUPERINFECTION; SYMPTOM; SYPHILIS; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; COMORBIDITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MIDDLE AGED; SYPHILIS; WORLD HEALTH ORGANIZATION;

EID: 3042607992     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(04)01061-8     Document Type: Review

References (143)

1. Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 290:2003;1510-1514
2. Arora PN, Sastry CV. HIV infection and genital ulcer disease. Indian J Sex Transm Dis. 13:1992;71-73
3. Bruisten SM, Cairo I, Fennema H, et al. Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands. J Clin Microbiol. 39:2001;601-605
4. Kinghorn GR. Syphilis. Cohen J, Powderly WG. Infectious diseases. 2nd edn:2004;807-816 Mosby, London
5. Walker DG, Walker GJ. Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infect Dis. 2:2002;432-436
6. WHO. World Health Organization website. http://www.who.int.
7. Borisenko KK, Tichonova LI, AM R. Syphilis and other sexually transmitted infections in the Russian Federation. Int J STD AIDS. 10:1999;665-668
8. van den Hoek A, Yuliang F, Dukers NH, et al. High prevalence of syphilis and other sexually transmitted diseases among sex workers in China: potential for fast spread of HIV. AIDS. 13:2001;753-759
9. Sugihantono A, Slidell M, Syaifudin A, et al. Syphilis and HIV prevalence among commercial sex workers in Central Java, Indonesia: risk-taking behavior and attitudes that may potentiate a wider epidemic. AIDS Patient Care STDS. 17:2003;595-600
10. Ashton M, Sopwith W, Clark P, McKelvey D, Lighton L, Mandal D. An outbreak no longer: factors contributing to the return of syphilis in Greater Manchester. Sex Transm Infect. 79:2003;291-293
11. Hook EW 3rd. Elimination of syphilis transmission in the United States: historic perspectives and practical considerations. Trans Am Clin Climatol Assoc 1999; 110: 195-203; 203-04.
12. Doherty L, Fenton KA, Jones J, et al. Syphilis: old problem, new strategy. BMJ. 325:2002;153-156
13. Ciesielski CA. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep. 5:2003;145-152
14. HPA. Health Protection Agency website, http://www.hpa.org.uk.
15. CDR. Recent developments in syphilis epidemiology. Communicable Disease Reports 2003; 13.
16. Domegan L, Cronin M, Thornton L, Creamer E, O'Lorcain P, Hopkins S. Enhanced surveillance of syphilis. Epi-Insight. 3:2002;2-3
17. Blocker ME, Levine WC, St Louis ME. HIV prevalence in patients with syphilis, United States. Sex Transm Dis. 27:2000;53-59
18. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho Martinez F. Sexually transmitted diseases in 1161 HIV-positive patients: a 38-month prospective study in southern Spain. J Eur Acad Dermatol Venereol. 11:1998;221-226
19. Schofer H, Imhof M, Thoma-Greber E, et al. Active syphilis in HIV infection: a multicentre retrospective survey. Genitourin Med. 72:1996;176-181
20. Nandwani R, Fisher M. Clinical standards for the screening and management of acquired syphilis in HIV-positive adults. http://www.mssvd.org (accessed December 3, 2003).
21. Chesson HW, Dee TS, Aral SO. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex Transm Dis. 30:2003;419-424
22. Dukers NH, Goudsmit J, de Wit JB, Prins M, Weverling GJ, Coutinho RA. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS. 15:2001;369-378
23. Dodds JP, Nardone A, Mercey DE, Johnson AM. Increase in high risk sexual behaviour among homosexual men, London 1996-98: cross sectional, questionnaire study. BMJ. 320:2000;1510-1511
24. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 75:1999;3-17
25. Urassa WK, Kapiga SH, Msamanga GI, Antelman G, Coley J, Fawzi WW. Risk factors for syphilis among HIV-1-infected pregnant women in Dar es Salaam, Tanzania. Afr J Reprod Health. 5:2001;54-62
26. Chesson HW, Pinkerton SD, Irwin KL, Rein D, Kassler WJ. New HIV cases attributable to syphilis in the USA: estimates from a simplified transmission model. AIDS. 13:1999;1387-1396
27. Chesson HW, Pinkerton SD, Voigt R, Counts GW. HIV infections and associated costs attributable to syphilis coinfection among African Americans. Am J Public Health. 93:2003;943-948
28. Egglestone SI, Turner AJ. Serological diagnosis of syphilis. Commun Dis Public Health. 3:2000;158-162
29. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 8:1995;1-21
30. Anderson J, Mindel A, Tovey SJ, Williams P. Primary and secondary syphilis, 20 years' experience. 3: dagnosis, treatment, and follow up. Genitourin Med. 65:1989;239-243
31. Nandwani R, Evans DT. Are you sure it's syphilis? A review of false positive serology. Int J STD AIDS. 6:1995;241-248
32. Taniguchi S, Osato K, Hamada T. The prozone phenomenon in secondary syphilis. Acta Derm Venereol. 75:1995;153-154
33. Hicks CB, Benson PM, Lupton GP, Tramont EC. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med. 107:1987;492-495
34. Augenbraun M, Rolfs R, Johnson R, Joesoef R, Pope V. Treponemal specific tests for the serodiagnosis of syphilis. Sex Transm Dis. 25:1998;549-552
35. Haslett P, Laverty M. The prozone phenomenon in syphilis associated with HIV infection. Arch Intern Med. 154:1994;1643-1644
36. Jurado RL, Campbell J, Martin PD. Prozone phenomenon in secondary syphilis. Has its time arrived? Arch Intern Med. 153:1993;2496-2498
37. Malone JL, Wallace MR, Hendrick BB, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med. 99:1995;55-63
38. Janier M, Chastang C, Spindler E, et al. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology. 198:1999;362-369
39. Rompalo AM, Cannon RO, Quinn TC, Hook EW. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection 3rd. J Infect Dis. 165:1992;1124-1126
40. Fiumara NJ. Reinfection primary and secondary syphilis: the post treatment serologic response. Sex Transm Dis. 4:1977;132-134
41. Gwanzura L, Latif A, Bassett M, Machekano R, Katzenstein DA, Mason PR. Syphilis serology and HIV infection in Harare, Zimbabwe. Sex Transm Infect. 75:1999;426-430
42. Kumar B, Gupta S, Muralidhar S. Mucocutaneous manifestations of secondary syphilis in north Indian patients: a changing scenario? J Dermatol. 28:2001;137-144
43. Mindel A, Tovey SJ, Timmins DJ, Williams P. Primary and secondary syphilis, 20 years' experience. 2. Clinical features. Genitourin Med. 65:1989;1-3
44. Bernal Ruiz AI, Gonzalez Ruiz A, Gutierrez Rodriguez C, Garcia Munoz M. Generalized macular rash with palmar-plantar involvement associated with lymphadenopathies. Secondary lues. Rev Clin Esp. 201:2001;101-102
45. Carbia SG, Lagodin C, Abbruzzese M, et al. Lichenoid secondary syphilis. Int J Dermatol. 38:1999;53-55
46. Jordaan HF, Louw M. The moth-eaten alopecia of secondary syphilis. A histopathological study of 12 patients. Am J Dermatopathol. 17:1995;158-162
47. Puavilai S, Charuwichitratana S, Polnikorn N, Sakuntabhai A, Timpatanapong P. Clinical and histopathological features of secondary syphilis. J Med Assoc Thai. 76:1993;85-92
48. Dave S, Gopinath DV, Thappa DM. Nodular secondary syphilis. Dermatol Online J. 9:2003;9
49. Erisir F, Senocak D, Inci E, Guclu E. Multiple plaques on the face and neck of a middle-aged man. Diagnosis: secondary syphilis. Ear Nose Throat J. 81:2002;55-56
50. Vural M, Ilikkan B, Polat E, Demir T, Perk Y. A premature newborn with vesiculobullous skin lesions. Eur J Pediatr. 162:2003;197-199
51. Engelkens HJ, ten Kate FJ, Vuzevski VD, van der Sluis JJ, Stolz E. Primary and secondary syphilis: a histopathological study. Int J STD AIDS. 2:1991;280-284
52. McBroom RL, Styles AR, Chiu MJ, Clegg C, Cockerell CJ, Radolf JD. Secondary syphilis in persons infected with and not infected with HIV-1: a comparative immunohistologic study. Am J Dermatopathol. 21:1999;432-441
53. Macaron NC, Cohen C, Chen SC, Arbiser JL. Cutaneous lesions of secondary syphilis are highly angiogenic. J Am Acad Dermatol. 48:2003;878-881
54. Papini M, Bettacchi A, Guiducci A. Nodular secondary syphilis. Br J Dermatol. 138:1998;704-705
55. Liotta EA, Turiansky GW, Berberian BJ, Sulica VI, Tomaszewski MM. Unusual presentation of secondary syphilis in 2 HIV-1 positive patients. Cutis 2000; 66: 383-86, 389.
56. Glover RA, Piaquadio DJ, Kern S, Cockerell CJ. An unusual presentation of secondary syphilis in a patient with human immunodeficiency virus infection. A case report and review of the literature. Arch Dermatol. 128:1992;530-534
57. Fonseca E, Garcia-Silva J, del Pozo J, Yebra MT, Cuevas J, Contreras F. Syphilis in an HIV infected patient misdiagnosed as leprosy. J Cutan Pathol. 26:1999;51-54
58. Pandhi RK, Singh N, Ramam M. Secondary syphilis: a clinicopathologic study. Int J Dermatol. 34:1995;240-243
59. Romero-Jimenez MJ, Suarez Lozano I, Fajardo Pico JM, Baron Franco B. Malignant syphilis in patient with human immunodeficiency virus (HIV): case report and literature review. Ann Med Interne. 20:2003;373-376
60. Sands M, Markus A. Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review. Clin Infect Dis. 20:1995;387-390
61. Wappner D, Carbia S, Gioseffi L, Schroh R, Losso MH. Diagnosis: malignant syphilis. Clin Infect Dis 1997; 25: 1343, 1447.
62. Don PC, Rubinstein R, Christie S. Malignant syphilis (lues maligna) and concurrent infection with HIV. Int J Dermatol. 34:1995;403-407
63. Tucker SC, Yates VM, Thambar IV. Unusual skin ulceration in an HIV-positive patient who had cutaneous syphilis and neurosyphilis. Br J Dermatol. 136:1997;946-948
64. Naidenov N, Lytsar BN, Skvortsov SV, et al. The combination of secondary recurrent syphilis and HIV infection. Voen Med Zh 1996; 317: 35-36, 79.
65. Hodgson TA, Rachanis CC. Oral fungal and bacterial infections in HIV-infected individuals: an overview in Africa. Oral Dis. 8:(suppl 2):2002;80-87
66. Reginato AJ. Syphilitic arthritis and osteitis. Rheum Dis Clin North Am. 19:1993;379-398
67. Keat A. Sexually transmitted arthritis syndromes. Med Clin North Am. 74:1990;1617-1631
68. Burgoyne M, Agudelo C, Pisko E. Chronic syphilitic polyarthritis mimicking systemic lupus erythematosus/rheumatoid arthritis as the initial presentation of human immunodeficiency virus infection. J Rheumatol. 19:1992;313-315
69. Rademacher SE, Radolf JD. Prominent osseous and unusual dermatologic manifestations of early syphilis in two patients with discordant serological statuses for human immunodeficiency virus infection. Clin Infect Dis. 23:1996;462-467
70. Gurland IA, Korn L, Edelman L, Wallach F. An unusual manifestation of acquired syphilis. Clin Infect Dis. 32:2001;667-669
71. Shore RN, Kiesel HA, Bennett HD. Osteolytic lesions in secondary syphilis. Arch Intern Med. 137:1977;1465-1467
72. Kastner RJ, Malone JL, Decker CF. Syphilitic osteitis in a patient with secondary syphilis and concurrent human immunodeficiency virus infection. Clin Infect Dis. 18:1994;250-252
73. Cintron R, Pachner AR. Spirochetal diseases of the nervous system. Curr Opin Neurol. 7:1994;217-222
74. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med. 121:1994;769-785
75. Dalal PM, Dalal KP. Cerebrovascular manifestations of neurosyphilis. J Assoc Physicians India. 40:1992;603-606
76. Hutto B. Syphilis in clinical psychiatry: a review. Psychosomatics. 42:2001;453-460
77. Katz DA, Berger JR, Duncan RC. Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Arch Neurol. 50:1993;243-249
78. Primavera A, Solaro C, Cocito L. De novo status epilepticus as the presenting sign of neurosyphilis. Epilepsia. 39:1998;1367-1369
79. Scheck DN, Hook EW, 3rd. Neurosyphilis. Infect Dis Clin North Am. 8:1994;769-795
80. Bordon J, Martinez-Vazquez C, Alvarez M, et al. Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis. 14:1995;864-869
81. Dreier A, Martinez V, Jimenez ML, Orus C, Jurgens A, Amesti C. Sudden bilateral deafness of luetic origin in an HIV-positive patient. Acta Otorrinolaringol Esp. 44:1993;315-317
82. Strom T, Schneck SA. Syphilitic meningomyelitis. Neurology. 41:1991;325-326
83. Tyler KL, Sandberg E, Baum KF. Medical medullary syndrome and meningovascular syphilis: a case report in an HIV-infected man and a review of the literature. Neurology. 44:1994;2231-2235
84. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med. 113:1990;872-881
85. Pavlovic DM, Milovic AM. Clinical characteristics and therapy of neurosyphilis in patients who are negative for human immunodeficiency virus. Srp Arh Celok Lek. 127:1999;236-240
86. Rotta NT, Silva C, Ohlweiler L, et al. AIDS neurologic manifestations in childhood. Rev Neurol. 29:1999;319-322
87. Wallace MR, Heaton RK, McCutchan JA, et al. Neurocognitive impairment in human immunodeficiency virus infection is correlated with sexually transmitted disease history. Sex Transm Dis. 24:1997;398-401
88. Mamidi A, DeSimone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol. 8:2002;158-167
89. Funnye AS, Akhtar AJ. Syphilis and human immunodeficiency virus co-infection. J Natl Med Assoc. 95:2003;363-382
90. Flores JL. Syphilis. A tale of twisted treponemes. West J Med. 163:1995;552-559
91. DiNubile MJ, Baxter JD, Mirsen TR. Acute syphilitic meningitis in a man with seropositivity for human immunodeficiency virus infection and normal numbers of CD4 T lymphocytes. Arch Intern Med. 152:1992;1324-1326
92. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis Feb. 189:2004;369-376
93. Marshall DW, Brey RL, Butzin CA, Lucey DR, Abbadessa SM, Boswell RN. CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected US Air Force personnel. J Acquir Immune Defic Syndr. 4:1991;777-781
94. Marra CM, Gary DW, Kuypers J, Jacobson MA. Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J Infect Dis. 174:1996;219-221
95. Luger AF, Schmidt BL, Kaulich M. Significance of laboratory findings for the diagnosis of neurosyphilis. Int J STD AIDS. 11:2000;224-234
96. Feraru ER, Aronow HA, Lipton RB. Neurosyphilis in AIDS patients: initial CSF VDRL may be negative. Neurology. 40:1990;541-543
97. Gordon SM, Eaton ME, George R, et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med. 331:1994;1469-1473
98. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med. 316:1987;1569-1572
99. Bordon J, Martinez-Vazquez C, de la Fuente-Aguado J, et al. Response to standard syphilis treatment in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 18:1999;729-732
100. Peters M, Gottschalk D, Boit R, Pohle HD, Ruf B. Meningovascular neurosyphilis in human immunodeficiency virus infection as a differential diagnosis of focal CNS lesions: a clinicopathological study. J Infect. 27:1993;57-62
101. Tien RD, Gean-Marton AD, Mark AS. Neurosyphilis in HIV carriers: MR findings in six patients. AJR Am J Roentgenol. 158:1992;1325-1328
102. Kikuchi S, Shinpo K, Niino M, Tashiro K. Subacute syphilitic meningomyelitis with characteristic spinal MRI findings. J Neurol. 250:2003;106-107
103. Srivastava T, Thussu A. MRI in syphilitic meningomyelitis. Neurol India. 48:2000;196-197
104. Marra CM, Longstreth WT Jr, Maxwell CL, Lukehart SA. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection. Sex Transm Dis. 23:1996;184-189
105. US Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 51:2002;1-78
106. MSSVD. UK guideline for the management of late syphilis, http://www.mssvd.org2002 (accessed December 3, 2003).
107. Spehn J, Jenzevski H, Pulz M, Emskotter T. Neurosyphilis in HIV infection: persistence after high-dose penicillin therapy. Dtsch Med Wochenschr. 113:1988;815-818
108. Guiloff RJ, Tan SV. Central nervous system opportunistic infections in HIV disease: clinical aspects. Baillieres Clin Neurol. 1:1992;103-154
109. Shann S, Wilson J. Treatment of neurosyphilis with ceftriaxone. Sex Transm Infect. 79:2003;415-416
110. Aldave AJ, King JA, Cunningham ET. Jr. Ocular syphilis. Curr Opin Ophthalmol. 12:2001;433-441
111. Spoor TC, Ramocki JM, Nesi FA, Sorscher M. Ocular syphilis 1986. Prevalence of FTA-ABS reactivity and cerebrospinal fluid findings. J Clin Neuroophthalmol 1987; 7: 191-95, 196-97.
112. Deschenes J, Seamone CD, Baines MG. Acquired ocular syphilis: diagnosis and treatment. Ann Ophthalmol. 24:1992;134-138
113. de Souza EC, Jalkh AE, Trempe CL, Cunha S, Schepens CL. Unusual central chorioretinitis as the first manifestation of early secondary syphilis. Am J Ophthalmol. 105:1988;271-276
114. Friberg TR. Syphilitic chorioretinitis. Arch Ophthalmol. 107:1989;1676-1677
115. Browning DJ. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology. 107:2000;2015-2023
116. Jumper JM, Machemer R, Gallemore RP, Jaffe GJ. Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis. Retina. 20:2000;190-194
117. Halperin LS, Lewis H, Blumenkranz MS, Gass JD, Olk RJ, Fine SL. Choroidal neovascular membrane and other chorioretinal complications of acquired syphilis. Am J Ophthalmol. 108:1989;554-562
118. Weinstein JM, Lexow SS, Ho P, Spickards A. Acute syphilitic optic neuritis. Arch Ophthalmol. 99:1981;1392-1395
119. Currie JN, Coppeto JR, Lessell S. Chronic syphilitic meningitis resulting in superior orbital fissure syndrome and posterior fossa gumma. A report of two cases followed for 20 years. J Clin Neuroophthalmol. 8:1988;145-159
120. Arruga J, Valentines J, Mauri F, Roca G, Salom R, Rufi G. Neuroretinitis in acquired syphilis. Ophthalmology. 92:1985;262-270
121. Kramer M, Lynn W, Lightman S. HIV/AIDS and the eye. Hosp Med. 64:2003;421-424
122. Liu IH, Chen SJ, Chung YM, Chiou SH, Wong WW. Syphilitic uveitis as the initial manifestation of HIV infection. J Formos Med Assoc. 101:2002;642-645
123. Becerra LI, Ksiazek SM, Savino PJ, et al. Syphilitic uveitis in human immunodeficiency virus-infected and noninfected patients. Ophthalmology. 96:1989;1727-1730
124. Thami GP, Kaur S, Gupta R, Kanwar AJ, Sood S. Syphilitic panuveitis and asymptomatic neurosyphilis: a marker of HIV infection. Int J STD AIDS. 12:2001;754-756
125. Kuo IC, Kapusta MA, Rao NA. Vitritis as the primary manifestation of ocular syphilis in patients with HIV infection. Am J Ophthalmol. 125:1998;306-311
126. Zambrano W, Perez GM, Smith JL. Acute syphilitic blindness in AIDS. J Clin Neuroophthalmol. 7:1987;1-5
127. McLeish WM, Pulido JS, Holland S, Culbertson WW, Winward K. The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology. 97:1990;196-203
128. Passo MS, Rosenbaum JT. Ocular syphilis in patients with human immunodeficiency virus infection. Am J Ophthalmol. 106:1988;1-6
129. Zamani M, Garfinkel RA. Corticosteroid-induced modulation of acute syphilitic posterior placoid chorioretinitis. Am J Ophthalmol. 135:2003;891-894
130. Shalaby IA, Dunn JP, Semba RD, Jabs DA. Syphilitic uveitis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 115:1997;469-473
131. Sinzobahamvya N, Kalangu K, Hamel-Kalinowski W. Arterial aneurysms associated with human immunodeficiency virus (HIV) infection. Acta Chir Belg. 89:1989;185-188
132. Olmos JM, Fernandez-Ayala M, Gutierrez JA, Val JF, Gonzalez-Marcias J. Superior vena cava syndrome secondary to syphilitic aneurysm of the ascending aorta in a human immunodeficiency virus-infected patient. Clin Infect Dis. 27:1998;1331-1332
133. Lu SY, Eng HL. Secondary syphilis-related oral ulcers: report of four cases. Chang Gung Med J. 25:2002;683-688
134. Zaharopoulos P, Wong J. Cytologic diagnosis of syphilitic pleuritis: a case report. Diagn Cytopathol. 16:1997;35-38
135. Szczech LA. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. Clin Infect Dis. 33:2001;115-119
136. Kusner DJ, Ellner JJ. Syphilis - a reversible cause of nephrotic syndrome in HIV infection. N Engl J Med. 324:1991;341-342
137. MSSVD. UK guideline for the management of early syphilis. http://www.mssvd.org (accessed December 3, 2003).
138. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med. 337:1997;307-314
139. Stamm LV, HL B. A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother. 44:2000;806-807
140. Gruber F, Kastelan M, Cabrijan L, Simonic E, Brajac I. Treatment of early syphilis with azithromycin. J Chemother. 12:2000;240-243
141. CDC. Azithromycin treatment failures in syphilis infections - San Francisco, California, 2002-2003. MMWR Morb Mortal Wkly Rep. 53:2004;197-198
142. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis. 30:2000;540-544
143. Morgan CA, Lukehart SA, WC VV. Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K. Infect Immun. 71:2003;5605-5612